Language selection

Government of Canada / Gouvernement du Canada

Search

Good manufacturing practices inspection policy for drug establishments : POL-0011.: H139-39/2022E-PDF

"Establishments need a drug establishment license (DEL) to be authorized to conduct the following licensable activities: fabricate, package/label, test, import, distribute, or wholesale of drugs. Health Canada inspects these sites to verify requirements for good manufacturing practices (GMP) are met before DEL issuance. This helps ensure that safety and quality standards are met by those selling drugs to Canadians"--Purpose, page 4.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.909078&sl=0

Publication information
Department/Agency
  • Canada. Health Canada, issuing body.
TitleGood manufacturing practices inspection policy for drug establishments : POL-0011.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Politique d'inspection des bonnes pratiques de fabrication pour les établissements de drogues : POL-0011.
  • "Pub.: 210725."
  • Issued also in HTML format.
  • Includes bibliographical references (pages 20-22).
Publishing information
  • [Ottawa] : Health Canada = Santé Canada, April 7, 2022.
  • ©2022
Description1 online resource (22 pages)
ISBN9780660425481
Catalogue number
  • H139-39/2022E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: